Oncothyreon
Seattle, US
Find your way into Oncothyreon
Sign up to see every warm intro you have to Oncothyreon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncothyreon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SP
Scott PetersonExecutive
GC
Gary ChristiansonExecutive
DH
Diana HausmanExecutive
JE
Julia EastlandExecutive
JV
Jay VenkatesanExecutive
Board
RJ
Richard JacksonBoard director
TW
Ted W. LoveBoard director
DS
Daniel SpiegelmanBoard director
WV
W. Vickery StoughtonBoard director
CH
Christopher HenneyBoard director
Reported raises · per SEC filings
Form D private placements$22.9M disclosed across 1 round · 2014
▶$22.9MraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
▶$22.9MraisedAug 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott PetersonExecutive Officer
- Gary ChristiansonExecutive Officer
- Richard JacksonDirector
- Ted W. LoveDirector
- Diana HausmanExecutive Officer
- Robert L. KirkmanExecutive Officer, Director
- Julia EastlandExecutive Officer
- Daniel SpiegelmanDirector
- W. Vickery StoughtonDirector
- Jay VenkatesanExecutive Officer
- Christopher HenneyDirector
- Offering amount
- $22.9M
- Amount sold
- $22.9M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Oncothyreon raised?
- Oncothyreon has disclosed $22.9M raised across 1 round.
- Where is Oncothyreon headquartered?
- Oncothyreon is headquartered in Seattle, US.